
Sage Therapeutics: Zuranolone NDA Near-Term Tailwind (NASDAQ:SAGE)
globalmoments/iStock via Getty Images Investment summary There could be a selective growth opportunity for Sage Therapeutics, Inc. (NASDAQ:SAGE) should the market support its “zuranolone” deal with Biogen Inc. (BIIB). When we last reviewed the stock […]